Phase 1 29 trials
Phase 1
NCT01364051 May 2011 → Jun 2019 overdue cutaneous melanoma , metastatic melanoma , refractory malignant neoplasm National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT01160926 Jul 2010 → Oct 2013 rectal carcinoma The Christie NHS Foundation Trust
Terminated
No outcome recorded
Phase 1
NCT01131234 May 2010 → Sep 2014 adult anaplastic ependymoma , adult brainstem glioma , adult glioblastoma , anaplastic astrocytoma +15 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00979862 Mar 2010 → May 2012 adult glioblastoma , giant cell glioblastoma , gliosarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01065662 Feb 2010 → Sep 2013 cervical cancer , endometrial cancer , fallopian tube cancer , ovarian cancer +1 Susana M. Campos, MD
Completed
No outcome recorded
Phase 1
NCT00981721 Sep 2009 → May 2010 high grade malignant neoplasm AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00937482 Aug 2009 → Mar 2011 male breast carcinoma , malignant colon neoplasm , melanoma , metastatic malignant neoplasm in the brain +3 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00960349 Aug 2009 → Jan 2010 gastric cancer AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00750841 Sep 2008 → Jul 2009 overdue cancer AstraZeneca
Active not recruiting
No outcome recorded
Phase 1
NCT00750425 Aug 2008 → Apr 2009 cancer AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00748891 Aug 2008 → Feb 2010 cancer AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00621361 Feb 2008 → Aug 2009 lung cancer AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00621725 Jan 2008 → Jul 2010 cancer of unknown primary site AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00539331 Sep 2007 → Sep 2008 non-small cell lung carcinoma AstraZeneca
Terminated
No outcome recorded
Phase 1
NCT00503204 Sep 2007 → Dec 2008 brain neoplasm , glioblastoma AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00458731 May 2007 → Dec 2013 Burkitt lymphoma , Hodgkins lymphoma , MALT lymphoma , T-cell large granular lymphocyte leukemia +19 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00475956 May 2007 → Oct 2008 neoplasm AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00321581 May 2006 → Oct 2011 acute myeloid leukemia , refractory malignant neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00326664 Mar 2006 → Jul 2015 atypical teratoid rhabdoid tumor , cerebellar astrocytoma , childhood brain meningioma , childhood brain stem glioma +13 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00243347 Dec 2005 → May 2008 head and neck neoplasm , non-small cell lung carcinoma AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00343408 Nov 2005 → Sep 2007 colorectal cancer , lung cancer NCIC Clinical Trials Group
Completed
No outcome recorded
Phase 1
NCT00503412 Nov 2005 → May 2006 metastatic malignant neoplasm AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00503477 Oct 2005 → Jul 2007 neoplasm AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00107250 Jan 2005 → Oct 2009 colorectal cancer , lung cancer NCIC Clinical Trials Group
Completed
No outcome recorded
Phase 1
NCT00502567 Jan 2005 → Nov 2007 —
AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00502060 Aug 2004 → Jun 2006 —
AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00502385 Apr 2004 → ? myeloid leukemia AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00502164 Mar 2004 → ? prostate adenocarcinoma AstraZeneca
Completed
No outcome recorded
Phase 1
NCT00501605 Feb 2003 → Apr 2005 neoplasm AstraZeneca
Completed
No outcome recorded
Show 19 more trials Phase 1/2 5 trials
Phase 1/2
NCT02484404 Jun 2015 → Oct 2027 expected breast cancer , colorectal cancer National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT01208051 Sep 2010 → Feb 2020 thyroid Hurthle cell carcinoma , thyroid gland papillary carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT01116648 Apr 2010 → Oct 2018 overdue fallopian tube carcinoma , ovarian endometrioid adenocarcinoma , ovarian serous surface papillary adenocarcinoma , primary peritoneal serous adenocarcinoma +1 National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT01064648 Mar 2010 → Jun 2018 overdue malignant epithelioid mesothelioma , malignant pleural mesothelioma , sarcomatoid mesothelioma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT00662506 Apr 2008 → Apr 2014 adult glioblastoma , giant cell glioblastoma , gliosarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2 54 trials
Phase 2
NCT04739800 Jun 2021 → Jan 2023 overdue fallopian tube clear cell adenocarcinoma , fallopian tube endometrioid adenocarcinoma , fallopian tube mucinous adenocarcinoma , fallopian tube serous adenocarcinoma +9 National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT04090567 Jul 2020 → Dec 2027 expected BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , Her2-receptor negative breast cancer M.D. Anderson Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT03741426 Jul 2020 → Nov 2025 renal cell carcinoma CCTU- Cancer Theme
Unknown
No outcome recorded
Phase 2
NCT04184518 May 2020 → Dec 2021 metastatic malignant neoplasm , uveal melanoma Spanish Melanoma Group
Withdrawn
No outcome recorded
Phase 2
NCT03851614 Apr 2019 → Jan 2027 expected colorectal cancer , leiomyosarcoma , pancreatic adenocarcinoma University Health Network, Toronto
Active not recruiting
No outcome recorded
Phase 2
NCT03699449 Nov 2018 → Sep 2022 —
Yonsei University
Unknown
No outcome recorded
Phase 2
NCT03660826 Sep 2018 → Dec 2024 overdue endometrial endometrioid adenocarcinoma , endometrial mixed adenocarcinoma , endometrial serous adenocarcinoma , endometrial undifferentiated carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT03570437 May 2018 → Jan 2023 carcinosarcoma , endometrial cancer University of Manchester
Unknown
No outcome recorded
Phase 2
NCT07648745 May 2018 → Jan 2025 fallopian tube carcinoma , intestinal obstruction , ovarian carcinoma , primary peritoneal carcinoma Prof Gordon Jayson
Completed
No outcome recorded
Phase 2
NCT02899728 Mar 2018 → Mar 2020 small cell lung carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT03334617 Dec 2017 → Sep 2024 overdue non-small cell lung carcinoma AstraZeneca
Active not recruiting
No outcome recorded
Phase 2
NCT02974621 Dec 2017 → Dec 2022 overdue glioblastoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT02893917 Aug 2017 → Mar 2023 overdue castration-resistant prostate carcinoma , metastatic prostate carcinoma , prostate adenocarcinoma , prostate neuroendocrine neoplasm National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT03314740 Jun 2017 → Apr 2021 ovarian neoplasm Mario Negri Institute for Pharmacological Research
Completed
No outcome recorded
Phase 2
NCT03117933 Mar 2017 → Mar 2021 ovarian cancer University of Oxford
Completed
No outcome recorded
Phase 2
NCT02889900 Jan 2017 → Aug 2019 —
AstraZeneca
Completed
No outcome recorded
Phase 2
NCT02498613 Aug 2016 → Jun 2022 overdue non-small cell lung carcinoma , pancreatic ductal adenocarcinoma , small cell lung carcinoma , triple-negative breast carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT02345265 May 2016 → Jul 2022 overdue fallopian tube endometrioid adenocarcinoma , fallopian tube serous adenocarcinoma , ovarian endometrioid adenocarcinoma , ovarian serous adenocarcinoma +1 National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT02340611 Jun 2015 → Jun 2018 ovarian cancer University Health Network, Toronto
Completed
No outcome recorded
Phase 2
NCT01391962 Jul 2011 → Nov 2023 alveolar soft part sarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01337401 Jul 2011 → Jul 2019 alveolar soft part sarcoma Institute of Cancer Research, United Kingdom
Unknown
No outcome recorded
Phase 2
NCT01229111 Oct 2010 → Mar 2014 cholangiocarcinoma , gallbladder carcinoma , periampullary adenocarcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT01260688 Oct 2010 → Jan 2013 hormone-resistant prostate carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01132820 Jun 2010 → Jan 2016 endometrial adenosquamous carcinoma , endometrial clear cell adenocarcinoma , endometrial serous adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01229930 Jun 2010 → Dec 2012 cervical cancer University of Glasgow
Completed
No outcome recorded
Phase 2
NCT01062425 Feb 2010 → Dec 2015 adult glioblastoma , gliosarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00942877 Jul 2009 → Sep 2018 alveolar soft part sarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00427973 May 2009 → Apr 2010 adult hepatocellular carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00475150 May 2008 → Jul 2011 acute myeloid leukemia with 11q23 abnormalities , acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) , acute myeloid leukemia with t(8;21)(q22;q22) translocation , myelodysplastic syndrome National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00588900 Mar 2008 → May 2010 colorectal cancer Alliance for Clinical Trials in Oncology
Terminated
No outcome recorded
Phase 2
NCT00527124 Nov 2007 → Jul 2012 prostate adenocarcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00326599 Jun 2007 → Apr 2009 lung cancer Alliance for Clinical Trials in Oncology
Completed
No outcome recorded
Phase 2
NCT00454805 Mar 2007 → Dec 2008 breast cancer AstraZeneca
Completed
No outcome recorded
Phase 2
NCT00458978 Feb 2007 → May 2013 hypopharynx squamous cell carcinoma , larynx verrucous carcinoma , major salivary gland carcinoma , metastatic squamous cell carcinoma +6 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00423332 Jan 2007 → Mar 2008 renal cell carcinoma AstraZeneca
Completed
No outcome recorded
Phase 2
NCT00436956 Oct 2006 → Feb 2010 prostate cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00410904 Oct 2006 → Jul 2013 non-small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00385203 Sep 2006 → Jun 2008 gastrointestinal stromal tumor , soft tissue sarcoma AstraZeneca
Completed
No outcome recorded
Phase 2
NCT00306891 Jun 2006 → Jan 2008 cancer AstraZeneca
Completed
No outcome recorded
Phase 2
NCT00321724 May 2006 → May 2007 B-cell chronic lymphocytic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00326872 May 2006 → Aug 2011 neurofibroma of spinal cord , neurofibromatosis type 1 , plexiform neurofibroma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00278343 Apr 2006 → Jun 2010 fallopian tube cancer , malignant epithelial tumor of ovary , primary peritoneal carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00303862 Mar 2006 → Mar 2011 clear cell renal carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00245063 Mar 2006 → Mar 2010 small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00243061 Jan 2006 → Mar 2012 acral lentiginous melanoma , iris melanoma , lentigo maligna melanoma , medium/large size posterior uveal melanoma +3 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00278889 Jan 2006 → Nov 2007 colorectal cancer AstraZeneca
Completed
No outcome recorded
Phase 2
NCT00305656 Jan 2006 → Apr 2012 adult glioblastoma , giant cell glioblastoma , gliosarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00227760 Dec 2005 → May 2013 renal cell carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00238394 Dec 2005 → Mar 2007 adult hepatocellular carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00309946 Dec 2005 → Sep 2010 malignant epithelioid mesothelioma , sarcomatoid mesothelioma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00264004 Nov 2005 → Jan 2007 neoplasm AstraZeneca
Completed
No outcome recorded
Phase 2
NCT00243074 Nov 2005 → Apr 2010 sarcomatoid mesothelioma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00275028 Oct 2005 → Mar 2010 fallopian tube cancer , malignant epithelial tumor of ovary , primary peritoneal serous adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00244881 Sep 2005 → Aug 2007 male breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Show 44 more trials Phase 2/3 4 trials
Phase 2/3
NCT02502266 May 2016 → Jun 2023 overdue fallopian tube clear cell adenocarcinoma , fallopian tube endometrioid adenocarcinoma , fallopian tube serous adenocarcinoma , fallopian tube transitional cell carcinoma +7 National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2/3
NCT00939848 Apr 2011 → Sep 2012 biliary tract neoplasm University College, London
Completed
No outcome recorded
Phase 2/3
NCT00384176 Aug 2006 → Nov 2009 colorectal cancer AstraZeneca
Completed
No outcome recorded
Phase 2/3
NCT00245154 Nov 2005 → Jul 2008 lung cancer NCIC Clinical Trials Group
Completed
No outcome recorded
Phase 3 5 trials
Phase 3
NCT03278717 Jun 2018 → Dec 2023 ovarian cancer University College, London
Unknown
No outcome recorded
Phase 3
NCT02446600 Mar 2016 → Feb 2020 overdue fallopian tube clear cell adenocarcinoma , fallopian tube transitional cell carcinoma , ovarian clear cell adenocarcinoma , ovarian endometrioid adenocarcinoma +5 National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 3
NCT00795340 Feb 2009 → Jan 2012 lung cancer NCIC Clinical Trials Group
Completed
No outcome recorded
Phase 3
NCT00777153 Oct 2008 → Apr 2010 glioblastoma AstraZeneca
Completed
No outcome recorded
Phase 3
NCT00399035 Nov 2006 → Mar 2010 colorectal cancer AstraZeneca
Completed
No outcome recorded
Phase not applicable 2 trials
— NCT02681237 Apr 2016 → Jan 2022 ovarian cancer University Health Network, Toronto
Completed
No outcome recorded
— NCT00310089 Jan 2006 → Jul 2007 breast cancer National Cancer Institute (NCI)
Completed
No outcome recorded